167 related articles for article (PubMed ID: 33833134)
1. Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
Kim HJ; Oh SH; Lee SH; Kim YB; Kim DY; Park SH; Ye BD; Yang SK; Kim KM
Gut Liver; 2021 Nov; 15(6):851-857. PubMed ID: 33833134
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study.
Wan J; Wang X; Zhang Y; Xue X; Li Y; Liu Z; Han S; Chen M; Nie Y; Shi Y; Liang J; Wu K
Can J Gastroenterol Hepatol; 2021; 2021():1412663. PubMed ID: 34422708
[TBL] [Abstract][Full Text] [Related]
3. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
Geem D; Hercules D; Pelia RS; Venkateswaran S; Griffiths A; Noe JD; Dotson JL; Snapper S; Rabizadeh S; Rosh JR; Baldassano RN; Markowitz JF; Walters TD; Ananthakrishnan A; Sharma G; Denson LA; Hyams JS; Kugathasan S
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):368-376.e4. PubMed ID: 37802268
[TBL] [Abstract][Full Text] [Related]
4. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
5. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.
Lovasz BD; Lakatos L; Horvath A; Szita I; Pandur T; Mandel M; Vegh Z; Golovics PA; Mester G; Balogh M; Molnar C; Komaromi E; Kiss LS; Lakatos PL
World J Gastroenterol; 2013; 19(14):2217-26. PubMed ID: 23599648
[TBL] [Abstract][Full Text] [Related]
6. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children.
Kerur B; Machan JT; Shapiro JM; Cerezo CS; Markowitz J; Mack DR; Griffiths AM; Otley AR; Pfefferkorn MD; Rosh JR; Keljo DJ; Boyle B; Oliva-Hemker M; Kay MH; Saeed SA; Grossman AB; Sudel B; Kappelman MD; Schaefer M; Tomer G; Bousvaros A; Lerer T; Hyams JS; LeLeiko NS
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1467-1473. PubMed ID: 29486253
[TBL] [Abstract][Full Text] [Related]
7. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.
Thia KT; Sandborn WJ; Harmsen WS; Zinsmeister AR; Loftus EV
Gastroenterology; 2010 Oct; 139(4):1147-55. PubMed ID: 20637205
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-up and Predictors of Complicated Disease Behavior in Pediatric Crohn's Disease Patients.
Kori M; Avidan M; Topf-Olivestone C
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):471-475. PubMed ID: 34984988
[TBL] [Abstract][Full Text] [Related]
10. Impact of medical therapy on patients with Crohn's disease requiring surgical resection.
Fu YT; Hong T; Round A; Bressler B
World J Gastroenterol; 2014 Sep; 20(33):11808-14. PubMed ID: 25206286
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
[TBL] [Abstract][Full Text] [Related]
13. From Paris to Montreal: disease regression is common during long term follow-up of paediatric Crohn's disease.
Davies M; Dodd S; Coultate M; Ross A; Pears G; Gnaneswaran B; Tzivinikos C; Konidari A; Cheng J; Auth MK; Cameron F; Tamhne S; Renji E; Nair M; Baillie C; Collins P; Smith PJ; Subramanian S
Scand J Gastroenterol; 2020 Feb; 55(2):148-153. PubMed ID: 31928099
[No Abstract] [Full Text] [Related]
14. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.
Hwang SW; Kim JH; Im JP; Ye BD; Koo HS; Huh KC; Cheon JH; Kim YS; Kim YH; Han DS; Kim WH; Kim JS;
J Gastroenterol Hepatol; 2017 Oct; 32(10):1716-1722. PubMed ID: 28251684
[TBL] [Abstract][Full Text] [Related]
15. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
Cernoch PS; Fournier N; Zeitz J; Scharl M; Morell B; Greuter T; Schreiner P; Misselwitz B; Safroneeva E; Schoepfer AM; Vavricka SR; Rogler G; Biedermann L;
Dig Dis Sci; 2020 Sep; 65(9):2654-2663. PubMed ID: 31797187
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn's Disease: A Single-Centre Experience.
Kim HJ; Oh SH; Kim DY; Lee HS; Park SH; Yang SK; Kim KM
J Crohns Colitis; 2017 Feb; 11(2):157-164. PubMed ID: 27651220
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna Classification.
Dorn SD; Abad JF; Panagopoulos G; Korelitz BI
Inflamm Bowel Dis; 2004 May; 10(3):201-6. PubMed ID: 15290912
[TBL] [Abstract][Full Text] [Related]
18. Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Plevris N; Fulforth J; Lyons M; Siakavellas SI; Jenkinson PW; Chuah CS; Lucaciu L; Pattenden RJ; Arnott ID; Jones GR; Lees CW
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1835-1844.e6. PubMed ID: 32798706
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
Suárez Ferrer C; González-Lama Y; González-Partida I; Calvo Moya M; Vera Mendoza I; Matallana Royo V; Arevalo Serrano J; Abreu Garcia L
Dig Dis Sci; 2019 Mar; 64(3):875-879. PubMed ID: 30542812
[TBL] [Abstract][Full Text] [Related]
20. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
